APPLAUSE focused specifically on advanced packaging for photonics, optics, and electronics to reduce manufacturing costs across Europe.
OY EVERON AB
Finnish SME providing advanced packaging expertise for photonics, MEMS, and microfabricated medical devices in European consortia.
Their core work
OY EVERON AB is a Finnish private SME based in Turku that specializes in advanced packaging and microfabrication technologies for photonics, optics, and electronics. Their work focuses on the industrial manufacturing side of component production — turning research-grade sensors, transceivers, and MEMS devices into manufacturable products through packaging innovation. They bring practical semiconductor manufacturing and assembly expertise to large European consortia, particularly for applications spanning light sensing, thermal infrared detection, datacom transceivers, and cardiac monitoring. As a private company participating in Innovation Actions, their role is likely to contribute manufacturing process know-how that accelerates the commercialization of microfabricated components.
What they specialise in
MEMS appears as a keyword in APPLAUSE, and Moore4Medical targets microfabricated medical devices — both require precision fabrication competence.
APPLAUSE lists light sensors, thermal infrared sensors, and gas measurement as application targets for their packaging work.
Moore4Medical (2020–2023) targets accelerated innovation in microfabricated medical devices, with cardiac monitoring as an explicit application.
APPLAUSE includes datacom transceivers among the packaged component types, indicating experience with optical communications hardware.
How they've shifted over time
Both projects fall within a narrow 2019–2020 entry window, making a long-term trajectory difficult to assess. However, the keyword shift is instructive: their first project (APPLAUSE) is densely application-specific — semiconductor packaging, optics, thermal and light sensors, cardiac monitoring, gas measurement — suggesting a broad multi-market packaging competence. Their second project (Moore4Medical) is framed around enabling technology platforms, signaling a move from component-specific work toward foundry-style platform thinking that supports multiple medical applications. The direction suggests a narrowing of focus toward medical microfabrication as a strategic vertical, using their generic packaging expertise as the underlying capability.
Everon appears to be repositioning from broad photonics packaging toward becoming an enabling platform supplier for microfabricated medical devices, which is a higher-margin and more defensible niche.
How they like to work
Everon participates exclusively as a consortium partner — they have never coordinated an H2020 project. Despite only two projects, they have engaged with 86 unique partners across 16 countries, which indicates participation in large, multi-stakeholder Innovation Action consortia rather than small focused partnerships. This pattern is typical of specialist SMEs that contribute a specific industrial process or manufacturing technology to consortia led by larger research institutes or industry players.
With 86 unique consortium partners across 16 countries from just two projects, Everon has been embedded in unusually broad European networks for its size — both APPLAUSE and Moore4Medical are large multi-partner Innovation Actions. Their reach is pan-European with no visible geographic concentration beyond their Finnish home base.
What sets them apart
Everon is a rare Finnish industrial SME with hands-on expertise in packaging microfabricated components — a capability gap that most research-heavy consortia struggle to fill. Their value is not in discovery but in manufacturability: they help translate lab-proven sensors and MEMS devices into formats that can be produced at scale and at lower cost. For consortium builders, an SME that bridges photonics manufacturing and medical devices in a single organization is unusual and practically useful for Innovation Actions that must demonstrate industrial readiness.
Highlights from their portfolio
- Moore4MedicalThe largest funded project for Everon (EUR 157,891) and the one that signals their strategic push into medical microfabrication — a high-growth sector with strong EU funding momentum.
- APPLAUSEReveals the full breadth of Everon's packaging expertise across five distinct application areas (optics, sensing, cardiac, gas, datacom) in a single project, making it the best evidence of their cross-market manufacturing competence.